These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8159685)

  • 1. Cyclin D1 expression is regulated by the retinoblastoma protein.
    Müller H; Lukas J; Schneider A; Warthoe P; Bartek J; Eilers M; Strauss M
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2945-9. PubMed ID: 8159685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
    J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical interaction of the retinoblastoma protein with human D cyclins.
    Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
    Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
    Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
    Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
    Ewen ME; Sluss HK; Sherr CJ; Matsushime H; Kato J; Livingston DM
    Cell; 1993 May; 73(3):487-97. PubMed ID: 8343202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E.
    Sofer-Levi Y; Resnitzky D
    Oncogene; 1996 Dec; 13(11):2431-7. PubMed ID: 8957085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
    Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
    J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.
    Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL
    Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different roles for cyclins D1 and E in regulation of the G1-to-S transition.
    Resnitzky D; Reed SI
    Mol Cell Biol; 1995 Jul; 15(7):3463-9. PubMed ID: 7791752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.
    Spitkovsky D; Steiner P; Gopalkrishnan RV; Eilers M; Jansen-Dürr P
    Oncogene; 1995 Jun; 10(12):2421-5. PubMed ID: 7784093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
    Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation.
    Marhin WW; Hei YJ; Chen S; Jiang Z; Gallie BL; Phillips RA; Penn LZ
    Oncogene; 1996 Jan; 12(1):43-52. PubMed ID: 8552398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
    Kato J; Matsushime H; Hiebert SW; Ewen ME; Sherr CJ
    Genes Dev; 1993 Mar; 7(3):331-42. PubMed ID: 8449399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519).
    Jadayel DM; Lukas J; Nacheva E; Bartkova J; Stranks G; De Schouwer PJ; Lens D; Bartek J; Dyer MJ; Kruger AR; Catovsky D
    Leukemia; 1997 Jan; 11(1):64-72. PubMed ID: 9001420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control.
    Gjetting T; Lukas J; Bartek J; Strauss M
    Biol Chem Hoppe Seyler; 1995 Jul; 376(7):441-6. PubMed ID: 7576242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
    Nielsen NH; Emdin SO; Cajander J; Landberg G
    Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
    Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.